These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31793708)

  • 1. Factors associated with anxiety disorders among patients with substance use disorders in Lebanon: Results of a cross-sectional study.
    Haddad C; Darwich MJ; Obeid S; Sacre H; Zakhour M; Kazour F; Nabout R; Hallit S; Tahan FE
    Perspect Psychiatr Care; 2020 Oct; 56(4):745-752. PubMed ID: 31793708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature.
    Turner S; Mota N; Bolton J; Sareen J
    Depress Anxiety; 2018 Sep; 35(9):851-860. PubMed ID: 29999576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity of migraine and psychiatric disorders among substance-dependent inpatients.
    McDermott MJ; Tull MT; Gratz KL; Houle TT; Smitherman TA
    Headache; 2014 Feb; 54(2):290-302. PubMed ID: 23848988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affective temperaments in Lebanese people with substance use disorder.
    Yehya Y; Haddad C; Obeid S; Tahan F; Nabout R; Hallit S; Kazour F
    Perspect Psychiatr Care; 2019 Jul; 55(3):478-485. PubMed ID: 30561045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Factors Affecting the Quality of Life Among Patients With Addiction in Lebanon.
    Hallit S; Haddad C; Obeid S; Kazour F; Nabout R; Darwich MJ; Tahan FE
    J Nerv Ment Dis; 2019 May; 207(5):378-383. PubMed ID: 30932987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirically derived subgroups of bipolar I patients with different comorbidity patterns of anxiety and substance use disorders in Han Chinese population.
    Tsai HC; Lu MK; Yang YK; Huang MC; Yeh TL; Chen WJ; Lu RB; Kuo PH
    J Affect Disord; 2012 Jan; 136(1-2):81-89. PubMed ID: 21906818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated behavioral treatments for comorbid anxiety and substance use disorders: A model for understanding integrated treatment approaches and meta-analysis to evaluate their efficacy.
    Wolitzky-Taylor K
    Drug Alcohol Depend; 2023 Dec; 253():110990. PubMed ID: 37866006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal reciprocal associations between depression, anxiety, and substance use disorders over three decades of life.
    Amendola S; Hengartner MP; Ajdacic-Gross V; Angst J; Rössler W
    J Affect Disord; 2022 Apr; 302():315-323. PubMed ID: 35093414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders.
    Goldstein BI; Levitt AJ
    J Affect Disord; 2007 Nov; 103(1-3):187-95. PubMed ID: 17328960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of substance use disorders on clinical outcomes in older-adult psychiatric inpatients.
    Lane SD; da Costa SC; Teixeira AL; Reynolds CF; Diniz BS
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e323-e329. PubMed ID: 29044798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Smit F; Vollebergh WA; Spijker J
    Am J Psychiatry; 2002 Apr; 159(4):620-9. PubMed ID: 11925301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alcohol and drug dependence on the course of depression.
    Agosti V; Levin FR
    Am J Addict; 2006; 15(1):71-5. PubMed ID: 16449095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
    Weich L; Pienaar W
    Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with alcohol use disorder: the role of depression, anxiety, stress, alexithymia and work fatigue- a population study in Lebanon.
    Obeid S; Akel M; Haddad C; Fares K; Sacre H; Salameh P; Hallit S
    BMC Public Health; 2020 Feb; 20(1):245. PubMed ID: 32070314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.